TrialBMC cancer2021

Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle invasive bladder cancer: a multicenter, randomized, non-comparative, phase II study (Oncodistinct 004 - AURA trial).

Nieves Martinez Chanza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.